Ayer Eye (300015) $ Aier Eye (SZ300015)$. Eye care stock. From 2016 through the third quarter of 2019, the company's return on equity was 21%, 21%, 18%, and 20%, respectively. Operating income growth was 26%, 49%, 34%, and 26%, respectively. Net income growth is 30%, 33%, 35%, and 37%, respectively. Dynamic P/E ratio of 77 times, total market capitalization of 127.9 billion.
Tiger Pharmaceuticals (300347). Innovative drug clinical services stock. From 2016 to the third quarter of 2019, the company's return on net assets is 9%, 13%, 17%, 17%, respectively. Operating revenue growth was 22%, 43%, 36%, and 27%, respectively. Net income growth is -10%, 114%, 56%, and 66%, respectively. Dynamic P/E ratio of 84 times, total market capitalization of 59.8 billion.
Venture Wellcome (300451). Healthcare information stock. From 2016 to the third quarter of 2019, the company's return on net assets is 9%, 8%, 9%, and 7%, respectively. Revenue growth was 28%, 110%, 11%, and 17%, respectively. Net income growth is 26%, 159%, 30%, and 65%, respectively. Dynamic P/E ratio of 74 times, total market capitalization of 18.3 billion.
Polypharma (300630). Anti-allergy, antibiotic drug stocks. From 2016 to the third quarter of 2019, the company's return on equity is 25%, 16%, 22% and 21%, respectively. Revenue growth was 22%, 30%, 92%, and 51%, respectively. Net income growth is 37%, 41%, 84%, and 70%, respectively. Dynamic price-earnings ratio of 64 times, total market capitalization of 17.7 billion.
Aide Bio (300685). Oncology precision medicine molecular diagnostic products stock. From 2016 to the third quarter of 2019, the company's return on net assets was 24%, 20%, 17% and 12.9%, respectively. Revenue growth was 43%, 30%, 32%, and 32%, respectively. Net profit growth is 217%, 40%, 34% and 13% respectively. Dynamic price-earnings ratio of 76 times, total market capitalization of 11.1 billion.
Pharmacite (300725). Drug molecular masonry stock. From 2016 through the third quarter of 2019, the company's return on equity is 21%, 22%, 22%, and 18%, respectively. Revenue growth was 38%, 45%, 75%, and 36%, respectively. Net income growth is 81%, 86%, 98%, and 25%, respectively. Dynamic price-earnings ratio of 81 times, total market capitalization of 12.7 billion.
Kanglong Huacheng (300759). Innovative drug service stocks
Myriad Medical (300760). Medical Device Stocks
GEM Constituent Index Stocks
(1) Teradek, Shenzhou Taiyue, Lepu Medical, Nanfeng, Pathfinder, Lemay Pharmaceuticals, Lixin, Dinghan Technology, Huamei Testing, YWL Lithium-Infrared Energy, Aier Ophthalmology, NetSuite Technology, Yinjiang, Robotics, Red Sun Pharmaceuticals, Huayi Brothers, Jinlong Electromechanical, Flower Flush, Steel Research Goner and New Zuobang.
(2) Shanghai Kai Bao, interactive entertainment, Tianyuan Dike, China Qingbao, Dinglong shares, Wanbangda, three-dimensional silk, blue cursor, Oriental Fortune, Nandu power supply, Bishuiyuan, Huayi Jiaxin, Sanjiu environmental protection, Huaping shares, digital Zhengtong, national technology, digital video, Silver Jie, Changxin science and technology, ShengYun environmental protection.
(3) E-Lianzhong, Zhenxin Technology, LeTV, Shunnet Technology, Changying Precision, Dongfang Risheng, Zhifei Bio, Huichuan Technology, Huace Film and Television, Dafu Science and Technology, Xianhe Environmental Protection, Watson Biological, Songcheng Performing Arts, Townshend Peihealth, Xiangxue Pharmaceuticals, Skyboat Culture, Shenwu Environmental Protection, Hengtai Aipu, Dongfang Guoxin, Wanda Information.
(3) Hande Information, Dongfulong, Zhonghaida, Tengbang International, Jiecheng, Neusoft Carrier, Tiehan Ecology, Hanyu Pharmaceuticals, Jurong shares, Juguang Technology, Tianyu Information, Xinwangda, Yihuaru, Thousand Mountain Pharmaceuticals, Shanghai Ganglian, Furet, Guanhao Biological, Dean Diagnostics, Ray Media, Weining Software
(4) Kaisan, Erkang Pharmaceuticals, Huayu Software, Hejia shares, sunlight power supply, Feilixin, Longma information, Huaru Banner, three six five network, palm fun technology, spinning pole information, trench energy conservation, Taige medicine, Beixinyuan, Mengcao drought, Boteng shares, Oriental net power, Feitian honesty, the three ring group, Lanshi technology.